DPN Check® — The Science Behind Our Nerve Testing

An FDA-cleared, point-of-care nerve conduction device backed by 35+ peer-reviewed studies — detecting hidden nerve damage in seconds.

FDA-Cleared · NC-stat® 35+ Peer-Reviewed Studies

Diabetes CareThe Lancet Diabetes & Endocrinology J. of Diabetes InvestigationPLOS ONE

The Science

Objective measurement, not guesswork

DPN Check® (NC-stat®) is an FDA-cleared point-of-care nerve conduction device backed by 35+ peer-reviewed studies published in leading journals — Diabetes Care, The Lancet Diabetes & Endocrinology, the Journal of Diabetes Investigation, and PLOS ONE.

Research shows DPN Check® not only identifies early nerve damage but can help predict the risk of kidney function decline, diabetic retinopathy progression, and overall health outcomes — risks that HbA1c alone may not detect.

The Advantages

Why DPN Check®?

Advanced, non-invasive nerve conduction testing trusted by clinicians worldwide — delivering objective results in seconds.

FDA-Cleared Technology

FDA-cleared nerve conduction testing technology — a regulated, objective standard for detecting peripheral nerve damage.

~90% Sensitivity vs EMG

Approximately 90% sensitivity compared to traditional electromyography (EMG) — without the discomfort of needle testing.

Non-Invasive & Painless

A completely non-invasive and painless procedure — no needles, no discomfort, and no recovery time required.

Results in 10–15 Seconds

Objective results are available within 10–15 seconds — enabling immediate discussion and decision-making at the point of care.

Widely Used Worldwide

Used across clinics and research settings worldwide as an objective standard for early nerve damage detection.

The Evidence

Measured, Objective Results

The numbers behind why DPN Check® has become a benchmark for early nerve damage detection.

90%

Approximately 90% sensitivity vs EMG — matching traditional electromyography without the needles.

15s

Objective results in as little as 15 seconds to a result, right at the point of care.

35+

Backed by 35+ peer-reviewed studies across clinics and research settings.

The Advantage

Early detection of hidden nerve damage enables timely intervention, helping prevent serious diabetes-related complications before symptoms appear.

Act Early

See what a sugar test can't

Book your FDA-cleared nerve assessment today.

Chat on WhatsApp